Article and Video CATEGORIES
Sym-004 Offers Hope for EGFR Wild Type Lung Cancer Patients
Eighty percent of lung cancer patients have wild type EGFR, meaning there is no EGFR mutation. Dr. Joan Schiller of UT Southwestern Medical Center discusses a new drug in development that may help those patients. February 2014
[powerpress]
Please feel free to offer comments and raise questions in our
discussion forums.
